USANA EPS Estimate Rises to $2.00 as Shares Drop 42.8%
Analysts have raised USANA Health Sciences' 2026 EPS estimate from $1.90 to $2.00 over the past 60 days, reflecting stronger outlook. Shares have slid 42.8% in the last six months despite earnings beating consensus in three of the past four quarters with an average surprise of 21.9%.
1. EPS Estimate Revision
Over the past 60 days, analysts boosted USANA Health Sciences' 2026 EPS forecast by 5.3%, raising it from $1.90 to $2.00. This upward revision follows a pattern of stronger-than-expected quarterly results and suggests improved profit margin assumptions.
2. Stock Price Trend
USANA shares have declined 42.8% over the last six months, reflecting a significant downtrend. The steep drop contrasts with the company’s history of earnings surprises and signals investor concerns about revenue growth.
3. Earnings Beat Record
USANA outperformed consensus in three of the trailing four quarters, delivering an average EPS surprise of 21.92%. Consistent beats have driven the recent estimate revisions, even as the stock remains under pressure.